<?xml version="1.0" encoding="UTF-8" standalone="no"?><document id="DDI-DrugBank.d455">
    <sentence id="DDI-DrugBank.d455.s0" text="In vitro studies of human CYP enzymes showed that entacapone inhibited the CYP enzymes 1A2, 2A6, 2C9, 2C19, 2D6, 2E1 and 3A only at very high concentrations (IC50 from 200 to over 1000 uM;">
        <entity charOffset="50-59" id="DDI-DrugBank.d455.s0.e0" text="entacapone" type="drug"/>
    </sentence>
    <sentence id="DDI-DrugBank.d455.s1" text="an oral 200 mg dose achieves a highest level of approximately 5 uM in people);"/>
    <sentence id="DDI-DrugBank.d455.s2" text="these enzymes would therefore not be expected to be inhibited in clinical use."><negationtags>these enzymes would therefore &lt;scope&gt; &lt;cue&gt; not &lt;/cue&gt; be expected to be inhibited in clinical use. &lt;/scope&gt;</negationtags></sentence>
    <sentence id="DDI-DrugBank.d455.s3" text="Protein Binding: Entacapone is highly protein bound (98%).">
        <entity charOffset="17-26" id="DDI-DrugBank.d455.s3.e0" text="Entacapone" type="drug"/>
    </sentence>
    <sentence id="DDI-DrugBank.d455.s4" text="In vitro studies have shown no binding displacement between entacapone and other highly bound drugs, such as warfarin, salicylic acid, phenylbutazone, and diazepam.">
        <entity charOffset="60-69" id="DDI-DrugBank.d455.s4.e0" text="entacapone" type="drug"/>
        <entity charOffset="109-116" id="DDI-DrugBank.d455.s4.e1" text="warfarin" type="drug"/>
        <entity charOffset="119-132" id="DDI-DrugBank.d455.s4.e2" text="salicylic acid" type="drug"/>
        <entity charOffset="135-148" id="DDI-DrugBank.d455.s4.e3" text="phenylbutazone" type="drug"/>
        <entity charOffset="155-162" id="DDI-DrugBank.d455.s4.e4" text="diazepam" type="drug"/>
        <pair ddi="false" e1="DDI-DrugBank.d455.s4.e0" e2="DDI-DrugBank.d455.s4.e1" id="DDI-DrugBank.d455.s4.p0"/>
        <pair ddi="false" e1="DDI-DrugBank.d455.s4.e0" e2="DDI-DrugBank.d455.s4.e2" id="DDI-DrugBank.d455.s4.p1"/>
        <pair ddi="false" e1="DDI-DrugBank.d455.s4.e0" e2="DDI-DrugBank.d455.s4.e3" id="DDI-DrugBank.d455.s4.p2"/>
        <pair ddi="false" e1="DDI-DrugBank.d455.s4.e0" e2="DDI-DrugBank.d455.s4.e4" id="DDI-DrugBank.d455.s4.p3"/>
        <pair ddi="false" e1="DDI-DrugBank.d455.s4.e1" e2="DDI-DrugBank.d455.s4.e2" id="DDI-DrugBank.d455.s4.p4"/>
        <pair ddi="false" e1="DDI-DrugBank.d455.s4.e1" e2="DDI-DrugBank.d455.s4.e3" id="DDI-DrugBank.d455.s4.p5"/>
        <pair ddi="false" e1="DDI-DrugBank.d455.s4.e1" e2="DDI-DrugBank.d455.s4.e4" id="DDI-DrugBank.d455.s4.p6"/>
        <pair ddi="false" e1="DDI-DrugBank.d455.s4.e2" e2="DDI-DrugBank.d455.s4.e3" id="DDI-DrugBank.d455.s4.p7"/>
        <pair ddi="false" e1="DDI-DrugBank.d455.s4.e2" e2="DDI-DrugBank.d455.s4.e4" id="DDI-DrugBank.d455.s4.p8"/>
        <pair ddi="false" e1="DDI-DrugBank.d455.s4.e3" e2="DDI-DrugBank.d455.s4.e4" id="DDI-DrugBank.d455.s4.p9"/>
    <negationtags>In vitro studies have shown &lt;scope&gt; &lt;cue&gt; no &lt;/cue&gt; binding displacement between entacapone and other highly bound drugs, such as warfarin, salicylic acid, phenylbutazone, and diazepam. &lt;/scope&gt;</negationtags></sentence>
    <sentence id="DDI-DrugBank.d455.s5" text="Drugs Metabolized by Catechol-O-methyltransferase (COMT): Hormone levels: Levodopa is known to depress prolactin secretion and increase growth hormone levels.">
        <entity charOffset="74-81" id="DDI-DrugBank.d455.s5.e0" text="Levodopa" type="drug"/>
    </sentence>
    <sentence id="DDI-DrugBank.d455.s6" text="Treatment with entacapone coadministered with levodopa/dopa decarboxylase inhibitor does not change these effects.">
        <entity charOffset="15-24" id="DDI-DrugBank.d455.s6.e0" text="entacapone" type="drug"/>
        <entity charOffset="46-53" id="DDI-DrugBank.d455.s6.e1" text="levodopa" type="drug"/>
        <entity charOffset="55-82" id="DDI-DrugBank.d455.s6.e2" text="dopa decarboxylase inhibitor" type="group"/>
        <pair ddi="false" e1="DDI-DrugBank.d455.s6.e0" e2="DDI-DrugBank.d455.s6.e1" id="DDI-DrugBank.d455.s6.p0"/>
        <pair ddi="false" e1="DDI-DrugBank.d455.s6.e0" e2="DDI-DrugBank.d455.s6.e2" id="DDI-DrugBank.d455.s6.p1"/>
        <pair ddi="false" e1="DDI-DrugBank.d455.s6.e1" e2="DDI-DrugBank.d455.s6.e2" id="DDI-DrugBank.d455.s6.p2"/>
    <negationtags>Treatment with entacapone coadministered with levodopa/dopa decarboxylase inhibitor does &lt;scope&gt; &lt;cue&gt; not &lt;/cue&gt; change these effects. &lt;/scope&gt;</negationtags></sentence>
    <sentence id="DDI-DrugBank.d455.s7" text="No interaction was noted with the MAO-B inhibitor selegiline in two multiple-dose interaction studies when entacapone was coadministered with a levodopa/dopa decarboxylase inhibitor (n=29).">
        <entity charOffset="34-48" id="DDI-DrugBank.d455.s7.e0" text="MAO-B inhibitor" type="group"/>
        <entity charOffset="50-59" id="DDI-DrugBank.d455.s7.e1" text="selegiline" type="drug"/>
        <entity charOffset="107-116" id="DDI-DrugBank.d455.s7.e2" text="entacapone" type="drug"/>
        <entity charOffset="144-151" id="DDI-DrugBank.d455.s7.e3" text="levodopa" type="drug"/>
        <entity charOffset="153-180" id="DDI-DrugBank.d455.s7.e4" text="dopa decarboxylase inhibitor" type="group"/>
        <pair ddi="false" e1="DDI-DrugBank.d455.s7.e0" e2="DDI-DrugBank.d455.s7.e1" id="DDI-DrugBank.d455.s7.p0"/>
        <pair ddi="false" e1="DDI-DrugBank.d455.s7.e0" e2="DDI-DrugBank.d455.s7.e2" id="DDI-DrugBank.d455.s7.p1"/>
        <pair ddi="false" e1="DDI-DrugBank.d455.s7.e0" e2="DDI-DrugBank.d455.s7.e3" id="DDI-DrugBank.d455.s7.p2"/>
        <pair ddi="false" e1="DDI-DrugBank.d455.s7.e0" e2="DDI-DrugBank.d455.s7.e4" id="DDI-DrugBank.d455.s7.p3"/>
        <pair ddi="false" e1="DDI-DrugBank.d455.s7.e1" e2="DDI-DrugBank.d455.s7.e2" id="DDI-DrugBank.d455.s7.p4"/>
        <pair ddi="false" e1="DDI-DrugBank.d455.s7.e1" e2="DDI-DrugBank.d455.s7.e3" id="DDI-DrugBank.d455.s7.p5"/>
        <pair ddi="false" e1="DDI-DrugBank.d455.s7.e1" e2="DDI-DrugBank.d455.s7.e4" id="DDI-DrugBank.d455.s7.p6"/>
        <pair ddi="false" e1="DDI-DrugBank.d455.s7.e2" e2="DDI-DrugBank.d455.s7.e3" id="DDI-DrugBank.d455.s7.p7"/>
        <pair ddi="false" e1="DDI-DrugBank.d455.s7.e2" e2="DDI-DrugBank.d455.s7.e4" id="DDI-DrugBank.d455.s7.p8"/>
        <pair ddi="false" e1="DDI-DrugBank.d455.s7.e3" e2="DDI-DrugBank.d455.s7.e4" id="DDI-DrugBank.d455.s7.p9"/>
    <negationtags>&lt;scope&gt; &lt;cue&gt; No &lt;/cue&gt; interaction was noted with the MAO-B inhibitor selegiline in two multiple-dose interaction studies when entacapone was coadministered with a levodopa/dopa decarboxylase inhibitor (n=29). &lt;/scope&gt;</negationtags></sentence>
    <sentence id="DDI-DrugBank.d455.s8" text="More than 600 Parkinsons disease patients in clinical trials have used selegiline in combination with entacapone and levodopa/dopa decarboxylase inhibitor.">
        <entity charOffset="71-80" id="DDI-DrugBank.d455.s8.e0" text="selegiline" type="drug"/>
        <entity charOffset="102-111" id="DDI-DrugBank.d455.s8.e1" text="entacapone" type="drug"/>
        <entity charOffset="117-124" id="DDI-DrugBank.d455.s8.e2" text="levodopa" type="drug"/>
        <entity charOffset="126-153" id="DDI-DrugBank.d455.s8.e3" text="dopa decarboxylase inhibitor" type="group"/>
        <pair ddi="false" e1="DDI-DrugBank.d455.s8.e0" e2="DDI-DrugBank.d455.s8.e1" id="DDI-DrugBank.d455.s8.p0"/>
        <pair ddi="false" e1="DDI-DrugBank.d455.s8.e0" e2="DDI-DrugBank.d455.s8.e2" id="DDI-DrugBank.d455.s8.p1"/>
        <pair ddi="false" e1="DDI-DrugBank.d455.s8.e0" e2="DDI-DrugBank.d455.s8.e3" id="DDI-DrugBank.d455.s8.p2"/>
        <pair ddi="false" e1="DDI-DrugBank.d455.s8.e1" e2="DDI-DrugBank.d455.s8.e2" id="DDI-DrugBank.d455.s8.p3"/>
        <pair ddi="false" e1="DDI-DrugBank.d455.s8.e1" e2="DDI-DrugBank.d455.s8.e3" id="DDI-DrugBank.d455.s8.p4"/>
        <pair ddi="false" e1="DDI-DrugBank.d455.s8.e2" e2="DDI-DrugBank.d455.s8.e3" id="DDI-DrugBank.d455.s8.p5"/>
    </sentence>
    <sentence id="DDI-DrugBank.d455.s9" text="As most entacapone excretion is via the bile, caution should be exercised when drugs known to interfere with biliary excretion, glucuronidation, and intestinal beta-glucuronidase are given concurrently with entacapone.">
        <entity charOffset="8-17" id="DDI-DrugBank.d455.s9.e0" text="entacapone" type="drug"/>
        <entity charOffset="207-216" id="DDI-DrugBank.d455.s9.e1" text="entacapone" type="drug"/>
        <pair ddi="false" e1="DDI-DrugBank.d455.s9.e0" e2="DDI-DrugBank.d455.s9.e1" id="DDI-DrugBank.d455.s9.p0"/>
    </sentence>
    <sentence id="DDI-DrugBank.d455.s10" text="These include probenecid, cholestyramine, and some antibiotics (e.g. erythromycin, rifamipicin, ampicillin and chloramphenicol).">
        <entity charOffset="14-23" id="DDI-DrugBank.d455.s10.e0" text="probenecid" type="drug"/>
        <entity charOffset="26-39" id="DDI-DrugBank.d455.s10.e1" text="cholestyramine" type="drug"/>
        <entity charOffset="51-61" id="DDI-DrugBank.d455.s10.e2" text="antibiotics" type="group"/>
        <entity charOffset="69-80" id="DDI-DrugBank.d455.s10.e3" text="erythromycin" type="drug"/>
        <entity charOffset="96-105" id="DDI-DrugBank.d455.s10.e4" text="ampicillin" type="drug"/>
        <entity charOffset="111-125" id="DDI-DrugBank.d455.s10.e5" text="chloramphenicol" type="drug"/>
        <pair ddi="false" e1="DDI-DrugBank.d455.s10.e0" e2="DDI-DrugBank.d455.s10.e1" id="DDI-DrugBank.d455.s10.p0"/>
        <pair ddi="false" e1="DDI-DrugBank.d455.s10.e0" e2="DDI-DrugBank.d455.s10.e2" id="DDI-DrugBank.d455.s10.p1"/>
        <pair ddi="false" e1="DDI-DrugBank.d455.s10.e0" e2="DDI-DrugBank.d455.s10.e3" id="DDI-DrugBank.d455.s10.p2"/>
        <pair ddi="false" e1="DDI-DrugBank.d455.s10.e0" e2="DDI-DrugBank.d455.s10.e4" id="DDI-DrugBank.d455.s10.p3"/>
        <pair ddi="false" e1="DDI-DrugBank.d455.s10.e0" e2="DDI-DrugBank.d455.s10.e5" id="DDI-DrugBank.d455.s10.p4"/>
        <pair ddi="false" e1="DDI-DrugBank.d455.s10.e1" e2="DDI-DrugBank.d455.s10.e2" id="DDI-DrugBank.d455.s10.p5"/>
        <pair ddi="false" e1="DDI-DrugBank.d455.s10.e1" e2="DDI-DrugBank.d455.s10.e3" id="DDI-DrugBank.d455.s10.p6"/>
        <pair ddi="false" e1="DDI-DrugBank.d455.s10.e1" e2="DDI-DrugBank.d455.s10.e4" id="DDI-DrugBank.d455.s10.p7"/>
        <pair ddi="false" e1="DDI-DrugBank.d455.s10.e1" e2="DDI-DrugBank.d455.s10.e5" id="DDI-DrugBank.d455.s10.p8"/>
        <pair ddi="false" e1="DDI-DrugBank.d455.s10.e2" e2="DDI-DrugBank.d455.s10.e3" id="DDI-DrugBank.d455.s10.p9"/>
        <pair ddi="false" e1="DDI-DrugBank.d455.s10.e2" e2="DDI-DrugBank.d455.s10.e4" id="DDI-DrugBank.d455.s10.p10"/>
        <pair ddi="false" e1="DDI-DrugBank.d455.s10.e2" e2="DDI-DrugBank.d455.s10.e5" id="DDI-DrugBank.d455.s10.p11"/>
        <pair ddi="false" e1="DDI-DrugBank.d455.s10.e3" e2="DDI-DrugBank.d455.s10.e4" id="DDI-DrugBank.d455.s10.p12"/>
        <pair ddi="false" e1="DDI-DrugBank.d455.s10.e3" e2="DDI-DrugBank.d455.s10.e5" id="DDI-DrugBank.d455.s10.p13"/>
        <pair ddi="false" e1="DDI-DrugBank.d455.s10.e4" e2="DDI-DrugBank.d455.s10.e5" id="DDI-DrugBank.d455.s10.p14"/>
    </sentence>
    <sentence id="DDI-DrugBank.d455.s11" text="No interaction with the tricyclic antidepressant imipramine was shown in a single-dose study with entacapone without coadministered levodopa/dopa-decarboxylase inhibitor.">
        <entity charOffset="24-47" id="DDI-DrugBank.d455.s11.e0" text="tricyclic antidepressant" type="group"/>
        <entity charOffset="49-58" id="DDI-DrugBank.d455.s11.e1" text="imipramine" type="drug"/>
        <entity charOffset="98-107" id="DDI-DrugBank.d455.s11.e2" text="entacapone" type="drug"/>
        <entity charOffset="132-139" id="DDI-DrugBank.d455.s11.e3" text="levodopa" type="drug"/>
        <entity charOffset="141-168" id="DDI-DrugBank.d455.s11.e4" text="dopa-decarboxylase inhibitor" type="group"/>
        <pair ddi="false" e1="DDI-DrugBank.d455.s11.e0" e2="DDI-DrugBank.d455.s11.e1" id="DDI-DrugBank.d455.s11.p0"/>
        <pair ddi="false" e1="DDI-DrugBank.d455.s11.e0" e2="DDI-DrugBank.d455.s11.e2" id="DDI-DrugBank.d455.s11.p1"/>
        <pair ddi="false" e1="DDI-DrugBank.d455.s11.e0" e2="DDI-DrugBank.d455.s11.e3" id="DDI-DrugBank.d455.s11.p2"/>
        <pair ddi="false" e1="DDI-DrugBank.d455.s11.e0" e2="DDI-DrugBank.d455.s11.e4" id="DDI-DrugBank.d455.s11.p3"/>
        <pair ddi="false" e1="DDI-DrugBank.d455.s11.e1" e2="DDI-DrugBank.d455.s11.e2" id="DDI-DrugBank.d455.s11.p4"/>
        <pair ddi="false" e1="DDI-DrugBank.d455.s11.e1" e2="DDI-DrugBank.d455.s11.e3" id="DDI-DrugBank.d455.s11.p5"/>
        <pair ddi="false" e1="DDI-DrugBank.d455.s11.e1" e2="DDI-DrugBank.d455.s11.e4" id="DDI-DrugBank.d455.s11.p6"/>
        <pair ddi="false" e1="DDI-DrugBank.d455.s11.e2" e2="DDI-DrugBank.d455.s11.e3" id="DDI-DrugBank.d455.s11.p7"/>
        <pair ddi="false" e1="DDI-DrugBank.d455.s11.e2" e2="DDI-DrugBank.d455.s11.e4" id="DDI-DrugBank.d455.s11.p8"/>
        <pair ddi="false" e1="DDI-DrugBank.d455.s11.e3" e2="DDI-DrugBank.d455.s11.e4" id="DDI-DrugBank.d455.s11.p9"/>
    <negationtags>&lt;scope&gt; &lt;cue&gt; No &lt;/cue&gt; interaction with the tricyclic antidepressant imipramine was shown in a single-dose study with entacapone without coadministered levodopa/dopa-decarboxylase inhibitor. &lt;/scope&gt;</negationtags></sentence>
</document>